A systematic review of the Trypanosoma cruzi genetic heterogeneity, host immune response and genetic factors as plausible drivers of chronic chagasic cardiomyopathy
Chagas disease is a complex tropical pathology caused by the kinetoplastid Trypanosoma cruzi. This parasite displays massive genetic diversity and has been classified by international consensus in at least six Discrete Typing Units (DTUs) that are broadly distributed in the American continent. The m...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2019
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22760
- Acceso en línea:
- https://doi.org/10.1017/S0031182018001506
https://repository.urosario.edu.co/handle/10336/22760
- Palabra clave:
- Cytokine
Host factor
Virulence factor
Cytokine
Virulence factor
Adaptive immunity
Chagas disease
Chronic disease
Cytokine production
Genetic heterogeneity
Genetic variability
Heredity
Human
Immune response
Metabolomics
Molecular epidemiology
Nonhuman
Pathophysiology
Priority journal
Review
Systematic review
Trypanosoma cruzi
Cardiomyopathy
Chagas disease
Genetics
Host parasite interaction
Immunology
Innate immunity
Parasitology
Trypanosoma cruzi
Cardiomyopathies
Chagas disease
Cytokines
Genetic heterogeneity
Host-parasite interactions
Humans
Trypanosoma cruzi
Virulence factors
Chagas disease
Chronic chagasic cardiomyopathy
Dtus
Genetic factors
Trypanosoma cruzi
Virulence
innate
Immunity
- Rights
- License
- Abierto (Texto Completo)
Summary: | Chagas disease is a complex tropical pathology caused by the kinetoplastid Trypanosoma cruzi. This parasite displays massive genetic diversity and has been classified by international consensus in at least six Discrete Typing Units (DTUs) that are broadly distributed in the American continent. The main clinical manifestation of the disease is the chronic chagasic cardiomyopathy (CCC) that is lethal in the infected individuals. However, one intriguing feature is that only 30-40% of the infected individuals will develop CCC. Some authors have suggested that the immune response, host genetic factors, virulence factors and even the massive genetic heterogeneity of T. cruzi are responsible of this clinical pattern. To date, no conclusive data support the reason why a few percentages of the infected individuals will develop CCC. Therefore, we decided to conduct a systematic review analysing the host genetic factors, immune response, cytokine production, virulence factors and the plausible association of the parasite DTUs and CCC. The epidemiological and clinical implications are herein discussed. © Cambridge University Press 2018. |
---|